|
Market Closed -
Börse Stuttgart
23:55:37 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 35.60 EUR | -0.56% |
|
+0.56% | -12.75% |
| 10-07 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
| 10-07 | European Equities Traded in US as ADRs Fall in Wednesday Trading | MT |
| Market Cap | 85.69B 95.98B 79.64B 72.5B 137B 9,284B 137B 959B 375B 4,732B 360B 352B 15,175B | P/E 2026 * |
11.6x | P/E 2027 * | 10x |
|---|---|---|---|---|---|
| Enterprise Value | 97.02B 109B 90.18B 82.09B 155B 10,512B 156B 1,086B 425B 5,358B 408B 399B 17,183B | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.86x |
| Free-Float |
88.34% | Yield 2026 * |
5.95% | Yield 2027 * | 6.3% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNY | Delayed | |
CBOE
| SNY | Real-time | |
|
London S.E.
| 0A2V | Delayed | |
|
Mexican S.E.
| SNY N | End-of-day quote | |
|
Tradegate
| SNW2 | Real-time | |
|
Boerse Muenchen
| SNW2 | Real-time | |
|
Deutsche Boerse AG
| SNW2 | Delayed | |
|
Börse Stuttgart
| SNW2 | Delayed |
Last Transcript: Sanofi
| 1 week | +0.56% | ||
| Current month | -2.20% | ||
| 1 month | -3.26% | ||
| 3 months | -7.29% | ||
| 6 months | -11.44% | ||
| Current year | -12.75% |
| 1 week | 34.8 |  | 35.8 |
| 1 month | 34.6 | | 37.6 |
| 3 years | 34.6 | | 55 |
| 5 years | 34.6 | | 55 |
| 10 years | 30.6 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | +0.56% | -15.64% | -29.50% | 95.94B | |
| +0.83% | +3.19% | +41.49% | +103.56% | 1,051B | |
| +1.93% | +2.11% | +37.08% | +65.09% | 630B | |
| +1.49% | +5.19% | +19.94% | +85.69% | 489B | |
| +2.26% | +0.90% | +69.32% | +40.53% | 359B | |
| +1.45% | +3.50% | +21.87% | +42.64% | 344B | |
| +1.17% | +2.37% | +11.71% | +35.14% | 272B | |
| +0.89% | +1.08% | -7.28% | +10.52% | 246B | |
| +1.82% | +2.94% | +42.99% | +52.95% | 224B | |
| +2.77% | +4.44% | +29.01% | +98.99% | 187B | |
| Average | +1.62% | +2.53% | +25.05% | +50.56% | 422.63B | |
| Weighted average by Cap. | +1.47% | +2.44% | +31.83% | +66.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.35B 53.03B 44.01B 40.06B 75.59B 5,130B 75.89B 530B 207B 2,614B 199B 195B 8,385B | 50.47B 56.53B 46.91B 42.7B 80.57B 5,468B 80.89B 565B 221B 2,787B 212B 208B 8,937B |
| Net income | 7.3B 8.17B 6.78B 6.17B 11.65B 791B 11.7B 81.69B 31.96B 403B 30.69B 30.02B 1,292B | 8.81B 9.87B 8.19B 7.46B 14.07B 955B 14.13B 98.66B 38.6B 487B 37.07B 36.26B 1,561B |
| Net Debt | 11.34B 12.7B 10.54B 9.59B 18.1B 1,228B 18.17B 127B 49.64B 626B 47.68B 46.63B 2,008B | 8B 8.96B 7.44B 6.77B 12.78B 867B 12.83B 89.59B 35.05B 442B 33.66B 32.92B 1,417B |
| Date | Price | Change |
|---|---|---|
| 09/10/26 | €35.60 | -0.56% |
| 08/10/26 | €35.80 | 0.00% |
| 07/10/26 | €35.80 | +2.29% |
| 06/10/26 | €35.00 | -0.57% |
| 05/10/26 | €35.20 | -0.56% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
Select your edition
All financial news and data tailored to specific country editions
